Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxymetazoline HCl 0.05% Nasal Gel in Healthy Adults with Nasal Congestion
NCT07582328Phase 2Completed
- Sponsor
- Bayer
- Start
- Apr 2026
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Mucinex Full Force Nasal Spray in nasal congestion, nasal obstruction, sponsored by Bayer. Started Apr 2026; status: completed.
02
Drugs
Mucinex Full Force Nasal Spray
03
Conditions
nasal congestionnasal obstruction
Beyond the preview
Go deeper on NCT07582328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07582328.